First payments made under PPRS scheme
March 7, 2014Sales and Marketing ABPI, NHS, abp. pars, government
The first payments in pharma’s new pricing deal with the Department of Health are to be made this month as …
US regulator to launch ‘openFDA’
March 6, 2014Manufacturing and Production, Medical Communications APIs, FDA, data, manufacturing, open fda
The FDA is planning to introduce a new digital resource in order to open up its data to the public …
Smartphone tech to help autism sufferers commended
March 6, 2014Medical Communications, Sales and Marketing NHS, asperger's, aspergers, autism, brain in hand, cloud, digital
Smartphone technology which helps people with autism to live more easily with their condition has been commended as part of …
Sanofi looking to hire Alstom’s chief executive
March 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, alstom, kron
Sanofi is proposing to replace Lord Douro at the French firm with Patrick Kron as its new independent director. Kron …
Manufacturing hitches cited for Lilly/BI drug rejection
March 6, 2014Manufacturing and Production, Sales and Marketing Boehringer, FDA, diabetes, lilly, manufacturing
The FDA has refused to approve a new diabetes treatment from Lilly and its partner Boehringer Ingelheim due to ongoing …
New chief executive for Parkinson’s Institute
March 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Carrolee Barlow, Parkinson’s Institute
The Parkinson’s Institute and Clinical Center has appointed neuroscience and neurodegeneration expert Dr Carrolee Barlow as its new chief executive. …
Alzheimer’s tie-up for Eisai and Biogen
March 6, 2014Research and Development, Sales and Marketing Alzheimer's, BAN2401, Biogen IDEC, E2609, Eisai
Eisai and Biogen Idec have joined forces to look for new Alzheimer’s treatments, developing and commercialising two of the Japanese …
Smart pills ‘set to boom’
March 5, 2014Medical Communications, Research and Development, Sales and Marketing frost and sullivan, rajan, smart pills, smartpills
There will be an explosion in the development of smart pills used for internal imaging and even drug delivery within …
Twitter useful for tracking HIV outbreaks
March 5, 2014Medical Communications, Sales and Marketing AIDS, HIV, Twitter, digital, flu, ucla, virus, wells
A study by UCLA researchers has shown that Twitter and social media can be used as a practical real-time tool …
Canbex Therapeutics hires chief medical officer
March 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canbex Therapeutics
UK biotech firm Canbex Therapeutics has appointed former Lilly head Dr Alberto Lledó as its new chief medical officer (CMO). …
NICE U-turn on Pfizer drug Inlyta
March 5, 2014Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta
NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …
Cobra agrees oncology deal with BioCancell
March 4, 2014Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology
Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …
Clinical studies still not being published
March 4, 2014Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr
Half of all trials registered on a US clinical study database are not being published in public journals. This is …
CluePoints appoints three heads
March 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cluepoints, colby, polvent, stephenne
Clinical trial data firm CluePoints has announced three new appointments to its global team. John Colby (pictured) and Elizabeth Polvent join …
Alexion ‘concerned’ over NICE draft
March 4, 2014Sales and Marketing NICE, aHUS, alexia, blood, eculizumab, soliris
Alexion Pharmaceuticals UK has expressed ‘concern’ that NICE has not yet allowed its rare disease treatment Soliris to be formally …
Exploring the Amber™ auto injector
March 4, 2014Manufacturing and Production amber autoinjector, auto injector, shl group
SHL first introduced the Amber™ auto injector utilizing Pushclick™ technology at the PDA (Parental Drug Association) event in Basel, Switzerland …
Print adverts’ prescribing info could be axed
March 3, 2014Medical Communications MHRA, OTC, medicines, prescribing
The UK drugs regulator is proposing new rules that could see pharma update safety information for their medicines online, whilst …
Roche lung cancer drug fails
March 3, 2014Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin
An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …
Xarelto lift for Bayer
March 3, 2014Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo
Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …
Cello unifies all its health agencies
March 3, 2014Medical Communications Cello, Cello Business Sciences, Insight Research Group, Mash Health Group, MedErgy HealthGroup, The MSI Consultancy
The Cello Group has unified all its health-orientated agencies in order to operate under one umbrella brand called Cello Health. …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
Alcami appoints Will Isom to lead laboratory services sales
